For many years, Viminco has developed specialty and niche pharmaceuticals for Nordic clients.
The background for these projects can be many. For a number of older pharmaceuticals, stricter legislation requires new documentation or new starting materials. Perhaps central starting materials (APIs) are no longer produced and therefore need to be changed. A project can also be more commercially driven where a generic version of a given product are to be made.
Apart from this generic development of pharmaceuticals, we are also involved in the development of original products.
We drive the process all the way from sourcing the starting materials to testing formulation, bioequivalence, stability program, expert reports and compiling dossiers. But if the client carries some of these competencies in-house, we adjust our tasks accordingly.
The development and the different phases are coordinated in close contact with the client.